Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04614662 · ClinicalTrials.gov registry record · NA

Symptom Screening Linked to Care Pathways

A NA study of Quality of Life and Pediatric Cancer, sponsored by The Hospital for Sick Children.

Completed
Registry status
NA
Development phase
445
Enrollment target
20
Study locations

NCT04614662 is a NA study of Quality of Life and Pediatric Cancer that has completed, run by The Hospital for Sick Children. The registered enrollment target is 445 participants, roughly in line with the 449-participant average among 107 other Quality of Life trials with a reported enrollment target. The trial reports 20 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04614662, a NA study of Quality of Life and Pediatric Cancer, has completed, sponsored by The Hospital for Sick Children.

COMPLETED
Registry status
NA
Development phase
445 participants
Enrollment target
20
Study locations

Study Summary

Most children with cancer survive because they are given intensive treatments, but unfortunately, these treatments are associated with distressing symptoms. To address this problem, we developed the Symptom Screening in Pediatrics Tool (SSPedi) so that children receiving cancer treatments can communicate their bothersome symptoms, and Supportive care Prioritization, Assessment and Recommendations for Kids (SPARK), a web-based application that links identified symptoms to supportive care guidelines for symptom management. To establish that these tools improve the lives of children newly diagnosed with cancer, we will conduct a trial that randomizes 20 pediatric cancer institutions and measures the impact of three times weekly symptom screening, symptom feedback to healthcare providers and the development of care pathways for symptom management to improve total symptom burden, fatigue and quality of life.

Interventions

  • BEHAVIORAL SPARK Symptom Screening Linked to Feedback to Providers

Study Locations (20)

Texas

  • Driscoll Children's Hospital - Corpus Christi
  • The University of Texas M. D. Anderson Cancer Center - Houston
  • The University of Texas Health Science Center at San Antonio - San Antonio

California

  • Children's Hospital Los Angeles - Los Angeles
  • The Leland Stanford Junior University - Redwood City

Florida

  • Nemours Children's Health, Jacksonville - Jacksonville
  • Nemours Children's Hospital, Florida - Orlando

Iowa

  • Unity Point Health - Blank Children's Hospital - Des Moines
  • The University of Iowa - Iowa City

New York

  • Roswell Park Comprehensive Cancer Center - Buffalo
  • The Trustees of Columbia University in the City of New York - New York

Arizona

  • Phoenix Children's Hospital - Phoenix

Colorado

  • University of Colorado Denver - Aurora

Connecticut

  • Connecticut Children's Medical Center - Hartford

Trial Details

FieldValue
Enrollment Target 445 participants
Start Date 2021-08-02
Est. Completion 2023-10-25
Phase NA

Sponsor

The Hospital for Sick Children

23 total trials

What the Registry Record Tells You About NCT04614662

The ClinicalTrials.gov registry entry for NCT04614662 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 445 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 449-participant average among 107 other Quality of Life trials with a reported enrollment target. The listed sponsor is The Hospital for Sick Children, which has 23 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Quality of Life appearing as the primary indexed condition, and to 1 intervention - of which SPARK Symptom Screening Linked to Feedback to Providers is the first listed.

NCT04614662 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Texas, California, Florida.

Frequently Asked Questions

What is clinical trial NCT04614662 about?

NCT04614662 is a clinical study titled "Symptom Screening Linked to Care Pathways". Most children with cancer survive because they are given intensive treatments, but unfortunately, these treatments are associated with distressing symptoms. To address this problem, we developed the Symptom Screening in Pediatrics Tool (SSPedi) so that children receiving cancer treatments can commun...

What is the current status of trial NCT04614662?

This trial is currently completed. It is a NA study. The enrollment target is 445 participants. The study started on 2021-08-02. Estimated completion is 2023-10-25.

What conditions does trial NCT04614662 study?

This clinical trial studies the following conditions: Quality of Life, Pediatric Cancer.

What interventions are being tested in trial NCT04614662?

The interventions under investigation include: SPARK Symptom Screening Linked to Feedback to Providers (BEHAVIORAL).

Who is sponsoring clinical trial NCT04614662?

This trial is sponsored by The Hospital for Sick Children, which has 23 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04614662 being conducted?

This trial has 20 study locations across Arizona, California, Colorado, Connecticut, Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Quality of Life

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.